Hikma Pharmaceuticals PLC HIK-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 05/03/24 BST
1,960.00quote price arrow up+35.00 (+1.82%)
52 week range
1,711.00 - 2,222.00
Loading...
  • Open1,937.00
  • Day High1,977.00
  • Day Low1,931.00
  • Prev Close1,925.00
  • 52 Week High2,222.00
  • 52 Week High Date08/10/23
  • 52 Week Low1,711.00
  • 52 Week Low Date11/30/23

Key Stats

  • Market Cap5,332.49M
  • Shares Out221.89M
  • 10 Day Average Volume413,795.5
  • Dividend57.03
  • Dividend Yield2.91%
  • Beta1.01
  • YTD % Change9.56

KEY STATS

  • Open1,937.00
  • Day High1,977.00
  • Day Low1,931.00
  • Prev Close1,925.00
  • 52 Week High2,222.00
  • 52 Week High Date08/10/23
  • 52 Week Low1,711.00
  • 52 Week Low Date11/30/23
  • Market Cap5,332.49M
  • Shares Out221.89M
  • 10 Day Average Volume413,795.5
  • Dividend57.03
  • Dividend Yield2.91%
  • Beta1.01
  • YTD % Change9.56

RATIOS/PROFITABILITY

  • EPS (TTM)67.59
  • P/E (TTM)29.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/21/2024
  • Div Amount37.1432
  • Split Date-
  • Split Factor-

Latest On Hikma Pharmaceuticals PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products, supported by its manufacturing facilities in the United States, Europe and Middle...
Said Darwazah
Executive Chairman of the Board
Mazen Darwazah
Executive Vice Chairman of the Board, President of MENA
Riad Mishlawi
Chief Executive Officer, Executive Director
Khalid Nabilsi
Chief Financial Officer
Susan Ringdal
Executive Vice President - Strategic Planning and Global Affairs
Address
1 New Burlington Place
London
W1S 2HR
United Kingdom